Takeda Pharmaceutical Co Stock Filter Stocks by Fundamentals
TKPHF Stock | USD 25.77 0.75 2.83% |
Takeda Pharmaceutical Co fundamentals help investors to digest information that contributes to Takeda Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Takeda Pink Sheet. The fundamental analysis module provides a way to measure Takeda Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Takeda Pharmaceutical pink sheet.
Takeda |
Did you try this?
Run Equity Search Now
Equity SearchSearch for actively traded equities including funds and ETFs from over 30 global markets |
All Next | Launch Module |
Takeda Fundamentals
Return On Equity | 0.0477 | |||
Return On Asset | 0.0247 | |||
Profit Margin | 0.07 % | |||
Operating Margin | 0.13 % | |||
Current Valuation | 75.53 B | |||
Shares Outstanding | 1.56 B | |||
Shares Owned By Insiders | 1.20 % | |||
Shares Owned By Institutions | 41.35 % | |||
Price To Earning | 27.54 X | |||
Price To Book | 0.97 X | |||
Price To Sales | 0.01 X | |||
Revenue | 3.57 T | |||
Gross Profit | 2.44 T | |||
EBITDA | 1.05 T | |||
Net Income | 230.06 B | |||
Cash And Equivalents | 645.99 B | |||
Cash Per Share | 417.82 X | |||
Total Debt | 4.14 T | |||
Debt To Equity | 0.81 % | |||
Current Ratio | 1.18 X | |||
Book Value Per Share | 3,973 X | |||
Cash Flow From Operations | 1.12 T | |||
Earnings Per Share | 1.33 X | |||
Price To Earnings To Growth | 0.58 X | |||
Number Of Employees | 47.35 K | |||
Beta | 0.7 | |||
Market Capitalization | 50.37 B | |||
Total Asset | 13.18 T | |||
Retained Earnings | 1.57 T | |||
Working Capital | 675.58 B | |||
Current Asset | 1.48 T | |||
Current Liabilities | 808.72 B | |||
Annual Yield | 0.04 % | |||
Five Year Return | 3.99 % | |||
Net Asset | 13.18 T | |||
Last Dividend Paid | 180.0 |
About Takeda Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Takeda Pharmaceutical Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Takeda Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Takeda Pharmaceutical Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Takeda Pharmaceutical is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Takeda Pink Sheet is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Takeda Pharmaceutical Co Stock. Highlighted below are key reports to facilitate an investment decision about Takeda Pharmaceutical Co Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Takeda Pharmaceutical Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Takeda Pharmaceutical information on this page should be used as a complementary analysis to other Takeda Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Takeda Pink Sheet analysis
When running Takeda Pharmaceutical's price analysis, check to measure Takeda Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Takeda Pharmaceutical is operating at the current time. Most of Takeda Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Takeda Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Takeda Pharmaceutical's price. Additionally, you may evaluate how the addition of Takeda Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
CEOs Directory Screen CEOs from public companies around the world | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |